A multicenter, double- blind, flexible-dose, 6-month extension trial comparing the safety and efficacy of asenapine with olanzapine in subjects who completed Protocol 25543 .
Phase 1
Active, not recruiting
- Conditions
- SchizophreniaMedDRA version: 8.1 Level: PT Classification code 10039626 Term: Schizophrenia
- Registration Number
- EUCTR2005-002169-35-IT
- Lead Sponsor
- ORGANON ITALIA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Recruiting
- Sex
- Not specified
- Target Recruitment
- 300
Inclusion Criteria
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method